Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2008;51:1545-1551
Published online before print April 14, 2008, doi: 10.1161/HYPERTENSIONAHA.108.112003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
51/6/1545    most recent
HYPERTENSIONAHA.108.112003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Masoud, M.
Right arrow Articles by Jacob, G.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Masoud, M.
Right arrow Articles by Jacob, G.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Related Collections
Right arrow Deep vein thrombosis
Right arrow Coagulation
Right arrow Thrombosis risk factors
Right arrow Coagulation and fibronolysis
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Other Research

(Hypertension. 2008;51:1545.)
© 2008 American Heart Association, Inc.


Original Articles

Orthostatic Hypercoagulability

A Novel Physiological Mechanism to Activate the Coagulation System

Muhannad Masoud; Galit Sarig; Benjamin Brenner; Giris Jacob

From the J. Recanati Autonomic Dysfunction Center and the Thrombosis and Hemostasis Unit, Medicine, Rambam Health Care Campus, and Bruce Rappaport Faculty of Medicine, Technion-IIT, Haifa, Israel.

Correspondence to Giris Jacob, J. Recanati Autonomic Dysfunction Center, Medicine, Rambam Medical Center, PO Box 9602, Haifa 31096, Israel. E-mail G_Jacob{at}rambam.health.gov.il

Orthostatic stress causes significant plasma shift and raises transmural pressure in lower extremities, resulting in an increase in endothelial activation and plasma proteins concentrations, possibly including coagulation factors. This may lead to activation of the coagulation system during standing. To test this hypothesis, we recruited 18 healthy volunteers (9 females and 9 males; mean age: 25±1.2 years; body mass index: 21.7±0.5 kg/m2). Hemodynamics, plasma shift (extrapolated from sequential hematocrit concentration), plasma proteins, and coagulation tests, including procoagulants; fibrinogen, factor V, and factor VIII activity; prothrombin fragments 1 and 2; and endothelial activation–related factors (tissue factor and von Willebrand factor), as well as protein C global pathway, were determined at rest supine and at 15 minutes, 30 minutes, and 60 minutes of still standing. Thirty minutes of standing caused a decrease in plasma volume by 12.0±0.5% and an increase in plasma protein by 13.0±0.7%. Fibrinogen, factor V, and factor VIII activity rose by 12.0±1.2%, 13.0±1.0%, and 40.0±6.0% (P<0.002 for all), respectively. Prothrombin fragments 1 and 2 were elevated by 150.0±30.0%. Tissue factor and von Willebrand factor increased by 30.0±9.0% and 17.4±51.0% (P<0.02 for both), respectively. However, protein C assay results decreased from 0.95±0.20 to 0.83±0.16 (P<0.001). We hereby introduce a novel physiological mechanism, "orthostatic procoagulation," that should be considered during coagulation tests. Furthermore, it could be extrapolated to the pathophysiology of stasis and venous thromboembolism.


Key Words: prolonged standing • coagulation • protein C global • endothelial activity